Magali Gilles

1.3k total citations
10 papers, 687 citations indexed

About

Magali Gilles is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Magali Gilles has authored 10 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Magali Gilles's work include SARS-CoV-2 and COVID-19 Research (4 papers), SARS-CoV-2 detection and testing (4 papers) and Mosquito-borne diseases and control (3 papers). Magali Gilles is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), SARS-CoV-2 detection and testing (4 papers) and Mosquito-borne diseases and control (3 papers). Magali Gilles collaborates with scholars based in France, Denmark and Mali. Magali Gilles's co-authors include Franck Touret, Xavier de Lamballerie, Rémi N. Charrel, Boris Pastorino, Antoine Nougaırède, Étienne Decroly, Jacques van Helden, Karine Barral, Bruno Coutard and Léa Lucıanı and has published in prestigious journals such as PLoS ONE, Scientific Reports and Emerging infectious diseases.

In The Last Decade

Magali Gilles

10 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magali Gilles France 8 472 157 115 86 84 10 687
Kaiming Tang Hong Kong 14 505 1.1× 119 0.8× 153 1.3× 40 0.5× 39 0.5× 33 856
Xihua Lian China 7 293 0.6× 74 0.5× 123 1.1× 47 0.5× 35 0.4× 18 553
Xiaoshan Su China 8 270 0.6× 90 0.6× 145 1.3× 46 0.5× 31 0.4× 15 591
Allen Wing‐Ho Chu Hong Kong 13 968 2.1× 105 0.7× 148 1.3× 41 0.5× 67 0.8× 23 1.2k
Mira Alt Germany 11 190 0.4× 192 1.2× 63 0.5× 36 0.4× 58 0.7× 16 616
Ronghui Liang China 13 507 1.1× 154 1.0× 185 1.6× 40 0.5× 22 0.3× 22 910
Nadine Ebert Switzerland 11 439 0.9× 157 1.0× 155 1.3× 16 0.2× 33 0.4× 19 722
Artur Szczepański Poland 12 466 1.0× 50 0.3× 170 1.5× 21 0.2× 51 0.6× 22 748
Taylor Heald‐Sargent United States 10 826 1.8× 43 0.3× 152 1.3× 77 0.9× 23 0.3× 20 1.1k
Nam‐Joo Lee South Korea 10 343 0.7× 94 0.6× 73 0.6× 16 0.2× 55 0.7× 20 543

Countries citing papers authored by Magali Gilles

Since Specialization
Citations

This map shows the geographic impact of Magali Gilles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magali Gilles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magali Gilles more than expected).

Fields of papers citing papers by Magali Gilles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magali Gilles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magali Gilles. The network helps show where Magali Gilles may publish in the future.

Co-authorship network of co-authors of Magali Gilles

This figure shows the co-authorship network connecting the top 25 collaborators of Magali Gilles. A scholar is included among the top collaborators of Magali Gilles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magali Gilles. Magali Gilles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Pastorino, Boris, Franck Touret, Magali Gilles, Xavier de Lamballerie, & Rémi N. Charrel. (2024). Current status of pathogen handling in European laboratories: focus on viral inactivation process. Frontiers in Bioengineering and Biotechnology. 12. 1422553–1422553. 2 indexed citations
2.
Pezzı, Laura, Magali Gilles, Paola Mariela Saba Villarroel, et al.. (2021). Long-Term Infectivity of Chikungunya Virus Stored in the Dark at 4°C. Vector-Borne and Zoonotic Diseases. 21(12). 989–993. 1 indexed citations
3.
4.
Touret, Franck, Jean‐Sélim Driouich, Maxime Cochin, et al.. (2021). Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2. Antiviral Research. 193. 105137–105137. 23 indexed citations
5.
Touret, Franck, Léa Lucıanı, Cécile Baronti, et al.. (2021). Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium. mBio. 12(4). e0085021–e0085021. 18 indexed citations
6.
Touret, Franck, Magali Gilles, Karine Barral, et al.. (2020). In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication. Scientific Reports. 10(1). 13093–13093. 261 indexed citations
7.
Pastorino, Boris, Franck Touret, Magali Gilles, Xavier de Lamballerie, & Rémi N. Charrel. (2020). Heat Inactivation of Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics?. Viruses. 12(7). 735–735. 102 indexed citations
8.
Pastorino, Boris, Franck Touret, Magali Gilles, Xavier de Lamballerie, & Rémi N. Charrel. (2020). Prolonged Infectivity of SARS-CoV-2 in Fomites. Emerging infectious diseases. 26(9). 2256–2257. 156 indexed citations
9.
Pastorino, Boris, Franck Touret, Magali Gilles, et al.. (2020). Evaluation of Chemical Protocols for Inactivating SARS-CoV-2 Infectious Samples. Viruses. 12(6). 624–624. 78 indexed citations
10.
Touret, Franck, Magali Gilles, Raphaëlle Klitting, et al.. (2018). Live Zika virus chimeric vaccine candidate based on a yellow fever 17-D attenuated backbone. Emerging Microbes & Infections. 7(1). 1–12. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026